Skip navigation
Skip navigation

Assessing the safety and cost-effectiveness of early nanodrugs

Vines, Timothy; Faunce, Thomas


This article provides a detailed examination of how the safety and cost-effectiveness elements of Australia's drug regulatory system will respond to nanomedicines. The case study investigated involves Abraxane, a newly developed anti-cancer agent. The article concludes by proposing some responses to the challenges which nanomedicines are likely to present to international and domestic agencies. Additionally, it considers whether the recommendation of the Australian Productivity Commission to...[Show more]

CollectionsANU Research Publications
Date published: 2009
Type: Journal article
Source: Journal of Law and Medicine


File Description SizeFormat Image
01_Faunce_Assessing_the_safety_and_2009.pdf159.85 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator